Introduction And Definition
- Sanger sequencing is the historical gold standard method for DNA sequencing and mutation screening.
- It is classified as a first-generation sequencing technology.
- The technique evaluates the specific sequence of a patient's DNA.
- The resulting DNA sequence is then compared to a normal reference population.
- This comparison allows for the precise detection of genetic alterations.
Core Principles And Methodology
Chain Termination Mechanism
- The technique is based on chain-termination methodology.
- It relies on the selective incorporation of chain-terminating dideoxynucleotides.
- This incorporation is catalyzed by the enzyme DNA polymerase.
- The entire sequencing process occurs during in vitro DNA replication.
Analysis And Visualization
- Sanger sequencing can only evaluate a part of a single gene at a given time.
- The technique is designed to sequence only one DNA fragment at a time.
- The final results of the sequencing are typically visualized on an electropherogram.
Target Mutations And Diagnostic Yield
Detectable Genetic Variants
- The technique accurately detects single nucleotide variants (SNVs).
- It is also utilized to detect small insertions and deletions, commonly known as indels.
- It provides an exceptionally high diagnostic sensitivity of greater than 99% for point mutations.
Clinical Indications In Pediatrics
Primary Diagnostic Uses
- It is the ideal testing modality when a distinct clinical phenotype points clearly to a single specific gene.
- It is highly recommended for conditions that exhibit minimal locus heterogeneity.
- It serves as the gold standard for analyzing small genes that contain fewer than 20 exons.
- It is highly useful for investigating known mutation hotspots within a gene.
Secondary And Supportive Uses
- It is utilized for the cascade screening of specific, known mutations in family members.
- It remains the gold standard for confirming variants that are initially identified by next-generation sequencing.
Clinical Examples And Applications
| Disease Category | Specific Condition | Target Gene For Sanger Sequencing |
|---|---|---|
| Inborn Errors Of Metabolism | Phenylketonuria (PKU) | PAH gene sequencing. |
| Monogenic Disorders | Cystic fibrosis | CFTR gene sequencing. |
| Neuromuscular Disorders | Duchenne muscular dystrophy | DMD gene sequencing for point mutations after deletions are ruled out. |
| Skeletal Dysplasias | Achondroplasia | Targeted testing for precise known mutations. |
Advantages And Limitations
| Feature | Description |
|---|---|
| Key Advantages | It is highly accurate for targeted genetic testing. |
| It remains the definitive gold standard for point mutation detection and confirmation. | |
| Major Limitations | It provides very low overall throughput. |
| It is highly time-consuming for large-scale genome analysis. | |
| The method is not easily scalable for comprehensive diagnostics. | |
| It is exceptionally expensive when analyzing multiple genes sequentially, potentially costing lakhs of rupees compared to broader sequencing methods. |
Comparison With Next-Generation Sequencing
| Feature | Sanger Sequencing | Next-Generation Sequencing (NGS) |
|---|---|---|
| Throughput | Low throughput (analyzes one fragment at a time). | High throughput (massively parallel sequencing). |
| Target Scope | Small genes or specific mutation hotspots. | Entire exome or whole genome. |
| Locus Heterogeneity | Best for minimal locus heterogeneity. | Best for extreme locus heterogeneity. |
| Cost-Effectiveness | Expensive for large-scale or multiple gene analysis. | Highly cost-effective for analyzing multiple targets simultaneously. |